KR100508764B1 - 콜로스트리닌을 포함하는 의약품 및 약제학적 조성물 - Google Patents

콜로스트리닌을 포함하는 의약품 및 약제학적 조성물 Download PDF

Info

Publication number
KR100508764B1
KR100508764B1 KR10-1999-7002904A KR19997002904A KR100508764B1 KR 100508764 B1 KR100508764 B1 KR 100508764B1 KR 19997002904 A KR19997002904 A KR 19997002904A KR 100508764 B1 KR100508764 B1 KR 100508764B1
Authority
KR
South Korea
Prior art keywords
delete delete
colostrinin
treatment
pharmaceutical composition
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-1999-7002904A
Other languages
English (en)
Korean (ko)
Other versions
KR20000048886A (ko
Inventor
마린 야누츠
요제프 리소브스키
안나 두보브스카-잉글로트
Original Assignee
루드빅 히르츠펠드 인스티튜트 오브 이무놀로지 앤드 엑스페리멘탈 세라피 폴리쉬 아카데미 오브 사이언스
조지아데스 바이오테크 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 루드빅 히르츠펠드 인스티튜트 오브 이무놀로지 앤드 엑스페리멘탈 세라피 폴리쉬 아카데미 오브 사이언스, 조지아데스 바이오테크 리미티드 filed Critical 루드빅 히르츠펠드 인스티튜트 오브 이무놀로지 앤드 엑스페리멘탈 세라피 폴리쉬 아카데미 오브 사이언스
Publication of KR20000048886A publication Critical patent/KR20000048886A/ko
Application granted granted Critical
Publication of KR100508764B1 publication Critical patent/KR100508764B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
KR10-1999-7002904A 1996-10-03 1997-10-03 콜로스트리닌을 포함하는 의약품 및 약제학적 조성물 Expired - Fee Related KR100508764B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLP.316416 1996-10-03
PL96316416A PL185442B1 (pl) 1996-10-03 1996-10-03 Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020057004215A Division KR20050046766A (ko) 1996-10-03 1997-10-03 콜로스트리닌을 포함하는 식품 보조제

Publications (2)

Publication Number Publication Date
KR20000048886A KR20000048886A (ko) 2000-07-25
KR100508764B1 true KR100508764B1 (ko) 2005-08-17

Family

ID=20068412

Family Applications (2)

Application Number Title Priority Date Filing Date
KR10-1999-7002904A Expired - Fee Related KR100508764B1 (ko) 1996-10-03 1997-10-03 콜로스트리닌을 포함하는 의약품 및 약제학적 조성물
KR1020057004215A Ceased KR20050046766A (ko) 1996-10-03 1997-10-03 콜로스트리닌을 포함하는 식품 보조제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020057004215A Ceased KR20050046766A (ko) 1996-10-03 1997-10-03 콜로스트리닌을 포함하는 식품 보조제

Country Status (18)

Country Link
US (2) US6852700B1 (enExample)
EP (1) EP0932623A1 (enExample)
JP (2) JP2001501929A (enExample)
KR (2) KR100508764B1 (enExample)
CN (2) CN1535722A (enExample)
AR (1) AR013612A1 (enExample)
AU (1) AU4565197A (enExample)
BR (1) BR9712259A (enExample)
CA (1) CA2266859C (enExample)
CZ (1) CZ298215B6 (enExample)
GB (1) GB2333453B (enExample)
HU (1) HUP9904368A3 (enExample)
IL (1) IL129211A (enExample)
PL (1) PL185442B1 (enExample)
RU (1) RU2217152C2 (enExample)
TR (1) TR199901022T2 (enExample)
WO (1) WO1998014473A1 (enExample)
ZA (1) ZA978885B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
BR9910725A (pt) 1998-05-27 2001-01-30 Gemma Biotechnology Ltd Indução de proteìnas e peptìdeos antibióticos por proteìnas lait/s cd14
EP1094824B1 (en) * 1998-06-10 2006-04-05 Albert B. Crum Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
GB9813031D0 (en) * 1998-06-16 1998-08-12 Regen Biotech Limited Dietary supplement
GB9912852D0 (en) * 1999-06-02 1999-08-04 Regen Therapeutics Plc Peptides
AU6917700A (en) * 1999-08-17 2001-03-13 University Of Texas System, The Use of colostrinin, constituent peptides thereof, and analogs thereof to promoteneural cell differentiation
US6852685B1 (en) * 1999-08-17 2005-02-08 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
US7119064B2 (en) 1999-08-17 2006-10-10 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
EP1224217A4 (en) * 1999-08-17 2006-05-24 Univ Texas USE OF COLOSTRININ, THOSE FORMING PEPTIDES, AND ANALOGS FROM INDUCING CYTOKINES
US6500798B1 (en) 1999-08-17 2002-12-31 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators
US6903068B1 (en) * 1999-08-17 2005-06-07 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
GB0001825D0 (en) * 2000-01-26 2000-03-22 Regen Therapeutics Plc Peptides
AU2000269178A1 (en) * 2000-08-17 2002-02-25 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
AU2000267883A1 (en) * 2000-08-17 2002-02-25 Regen Therapeutics Plc Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
AU2000269179A1 (en) * 2000-08-17 2002-02-25 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promoteneural cell differentiation
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
HUP0200172A2 (hu) * 2002-01-15 2003-11-28 András Bertha Eljárás tumorellenes hatóanyag kinyerésére
EP1567551A4 (en) * 2002-10-22 2008-03-12 Univ Texas COLOSTRININ AND PEPTIDES THEREOF AS MODULATORS OF INTRA-CELLULAR SIGNAL MOLECULES AND APOPTOSIS INHIBITORS
PL1613648T3 (pl) * 2003-03-11 2008-05-30 Regen Therapeutics Plc Oczyszczanie peptydów z siary
CN1313487C (zh) * 2003-06-10 2007-05-02 天津商学院 具有抗菌作用的免疫活性肽（Trpi）
WO2005041680A2 (en) * 2003-11-03 2005-05-12 Advanced Protein Systems A novel colostral fractionation process
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20070212367A1 (en) * 2006-03-13 2007-09-13 Keech Andrew M Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions
GB2436328A (en) * 2006-03-22 2007-09-26 Regen Therapeutics Plc Peptide derived from colostrinin
US20110098216A1 (en) * 2009-10-22 2011-04-28 Regen Therapeutics Plc Therapeutic uses of colostrinin
ITMI20111460A1 (it) * 2011-07-29 2013-01-30 Bionest Ltd Composizioni per la terapia adiuvante dell'anoressia comprendenti anticorpi, fattori di crescita e citochine isolati dal colostro dei mammiferi
EP2797610A1 (en) 2011-12-30 2014-11-05 BIONEST Ltd. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors
RU2642650C2 (ru) 2011-12-30 2018-01-25 Инномед С.А. Комбинация факторов роста, цитокинов, антибактериальных/антивирусных факторов, факторов стволовых клеток, белков комплемента с3а/с4а, иммуноглобулинов и хемотаксических факторов
ITMI20112433A1 (it) * 2011-12-30 2013-07-01 Bionest Ltd Composizioni per la terapia orale adiuvante dell'anoressia comprendenti anticorpi, antibatterici, fattori di crescita e citochine
GB201205856D0 (en) 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
PL235821B1 (pl) 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia Wysokoprolinowy kompleks peptydowy do zastosowania w profilaktyce i wspomaganiu leczenia zaburzeń i stanów wymagających podwyższania i/lub modulacji poziomu neurotropowego czynnika pochodzenia mózgowego jako oznaczonego w osoczu krwi biomarkera i zawierający go preparat
DE112015005883T5 (de) 2015-01-30 2017-09-28 Hewlett-Packard Development Company, L.P. M-äre zyklische codierung
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE90569T1 (de) 1988-04-19 1993-07-15 Biotest Pharma Gmbh Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
JP3174611B2 (ja) * 1992-02-28 2001-06-11 明治乳業株式会社 免疫賦活組成物
US5645834A (en) 1992-08-28 1997-07-08 Immuno-Dynamics, Inc. Method and product for treating failure of passive transfer and improving milk production in bovine species
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
DE4337654C2 (de) 1993-11-04 1996-08-08 Biotest Pharma Gmbh Verwendung boviner Kolostralmilch von nicht mit Viren hyperimmunisierten Tieren als Leberschutzpräparat
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
RU2062109C1 (ru) * 1994-11-28 1996-06-20 Товарищество с ограниченной ответственностью "Старк" Способ получения иммунного препарата
AU6641896A (en) 1995-08-07 1997-03-05 New England Medical Center Hospitals, Inc., The Infant formula and infant formula additives
DE19619990A1 (de) 1996-05-17 1997-11-20 Charlotte Adler Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie

Also Published As

Publication number Publication date
GB2333453B (en) 2001-05-30
GB2333453A (en) 1999-07-28
IL129211A0 (en) 2000-02-17
AR013612A1 (es) 2001-01-10
JP2001501929A (ja) 2001-02-13
GB9908331D0 (en) 1999-06-09
RU2217152C2 (ru) 2003-11-27
US6852700B1 (en) 2005-02-08
EP0932623A1 (en) 1999-08-04
PL316416A1 (en) 1998-04-14
CN1535722A (zh) 2004-10-13
ZA978885B (en) 1999-07-26
IL129211A (en) 2004-08-31
CA2266859A1 (en) 1998-04-09
CN1131712C (zh) 2003-12-24
BR9712259A (pt) 2000-01-25
US20050152985A1 (en) 2005-07-14
KR20050046766A (ko) 2005-05-18
CZ298215B6 (cs) 2007-07-25
PL185442B1 (pl) 2003-05-30
WO1998014473A1 (en) 1998-04-09
KR20000048886A (ko) 2000-07-25
HUP9904368A2 (hu) 2000-06-28
GB2333453A8 (en) 2000-11-27
TR199901022T2 (xx) 1999-07-21
CN1238782A (zh) 1999-12-15
HUP9904368A3 (en) 2000-07-28
CZ114999A3 (cs) 2000-06-14
CA2266859C (en) 2012-05-08
AU4565197A (en) 1998-04-24
JP2008174561A (ja) 2008-07-31

Similar Documents

Publication Publication Date Title
KR20050046766A (ko) 콜로스트리닌을 포함하는 식품 보조제
EP0313515B1 (en) A polypeptide growth factor from milk
US5221734A (en) Process for preparing a polypeptide growth factor for milk
CA2171281C (en) Immunomodulating compositions from bile
JP5247429B2 (ja) カゼイン由来ペプチドを含む医薬組成物及びその使用方法
US20020001625A1 (en) Growth-promoting agent
CA1263937A (en) Polypeptide factors from colostrum
US20080085299A1 (en) Peptides derived from colostrinin
Glass et al. Oral treatment of pernicious anemia with small doses of vitamin B12 combined with mucinous materials derived from the hog stomach
AU761148B2 (en) Colostrinin, and uses thereof
DE69715481T2 (de) Kininogen zur Stimulierung der Knochenbildung und Verhinderung der Knochenresorption
GB2352176A (en) Colostrinin and uses thereof
MXPA99003108A (en) Colostrinin, and uses thereof
US20050220801A1 (en) Immunopotentiators
PL195627B1 (pl) Zastosowania kolostryniny, kompozycje farmaceutyczne do leczenia przewlekłych chorób ośrodkowego układu nerwowego lub immunostymulacji i zastosowanie nonapeptydu
JP2001011094A (ja) 乳ホエ−タンパク中の生理活性物質およびその製造法ならびにその使用法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P20-X000 Errors in documents filed by the applicant or ip right owner corrected

St.27 status event code: A-2-2-P10-P20-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

A107 Divisional application of patent
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20110630

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20120802

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20130810

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20130810